U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603518) titled 'The Pharmacokinetics of a Hemp-Based Topical Product' on May 18.
Brief Summary: This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Cannabis
Intervention:
DRUG: CBD
CBD will be topically applied
DRUG: THC
THC will be topically applied
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Johns Hopkins University
Published by HT Digital Content Services with permission from Health Daily Dige...